Company Profiles

driven by the PitchBook Platform

Edison (Pharmaceuticals)

Description

Developer of redox drugs designed to discover new approaches to human health and disease. The company's redox drugs detects defects in the mitochondrial proteins, enabling healthcare professionals to treat mitochondrial diseases are genetic disorders.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$50M

Latest Deal Amount

$87.9M

Total Amount Raised

Description

Developer of redox drugs designed to discover new approaches to human health and disease. The company's redox drugs detects defects in the mitochondrial proteins, enabling healthcare professionals to treat mitochondrial diseases are genetic disorders.

Website:

www.edisonpharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

350 North Bernardo Avenue Mountain View, CA 94043United States +1 (650) 641-9200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Edison (Pharmaceuticals)'s full profile, request a free trial.

    Edison (Pharmaceuticals) Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Edison (Pharmaceuticals) Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Berg and Berg EnterprisesVenture CapitalMinority000 0000000 0000
    Dainippon Sumitomo PharmaLimited Partner000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Mitsui Global InvestmentPE/BuyoutMinority000 0000000 0000
    Morningside GroupVenture CapitalMinority000 0000000 0000
    Berg and Berg Enterprises Venture Capital
    Dainippon Sumitomo Pharma Limited Partner
    Individual Investor Angel (individual)
    Mitsui Global Investment PE/Buyout
    Morningside Group Venture Capital

    Edison (Pharmaceuticals) Executive Team (12)

    NameTitleBoard
    Seat
    Contact
    Info
    Guy Miller Ph.DChief Executive Officer & Chairman
    James GibsonChief Financial Officer
    Rebecca Shortle JDDirector, Intellectual Property
    Martin Thoolen Ph.DChief Drug Development Officer
    William Shrader Ph.DSenior Vice President, Innovation
    Guy Miller Ph.D Chief Executive Officer & Chairman
    James Gibson Chief Financial Officer
    Rebecca Shortle JD Director, Intellectual Property
    Martin Thoolen Ph.D Chief Drug Development Officer
    William Shrader Ph.D Senior Vice President, Innovation

    Edison (Pharmaceuticals) Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Guy Miller Ph.DEdison (Pharmaceuticals)Chief Executive Officer & Chairman000 0000
    Guy Miller Ph.D Chief Executive Officer & Chairman Edison (Pharmaceuticals)
    Request full access to PitchBook